Corrigendum to: National Heart Foundation of Australia & Cardiac Society of Australia and New Zealand: Comprehensive Australian Clinical Guideline for Diagnosing and Managing Acute Coronary Syndromes 2025" [Heart Lung Circ. 34(4) (2025) 309-397.]

  • other members of the Heart Foundation Working Group
  • , David Brieger
  • , Louise Cullen
  • , Tom Briffa
  • , Sarah Zaman
  • , Ian Scott
  • , Cynthia Papendick
  • , Kimberley Bardsley
  • , Angus Baumann
  • , Alexandra Sasha Bennett
  • , Robyn A Clark
  • , J James Edelman
  • , Sally C Inglis
  • , Lisa Kuhn
  • , Adam Livori
  • , Julie Redfern
  • , Hans Schneider
  • , Jeanine Stewart
  • , Liza Thomas
  • , Edwina Wing-Lun
  • Ling Zhang, Elaine Ho, Stacey Matthews

Research output: Contribution to journalComment/debate/opinionResearch

Abstract

Corrected:
National Heart Foundation of Australia & Cardiac Society of Australia and New Zealand: Comprehensive Australian Clinical Guideline for Diagnosing and Managing Acute Coronary Syndromes 2025
David Brieger, Louise Cullen, Tom Briffa ...
March 31, 2025

The authors provide the following changes to the original publication:

i. To clarify to whom the STEMI (ST-segment elevation myocardial infarction) recommendations apply, in the ‘Summary of Recommendations’ Table (‘Acute management of STEMI’ p314) a hashtag is added and the footnotes updated.

“#These recommendations apply to people with ECG changes that may not be recognised as STEMI but are indicative of ACOMI, specifically: high lateral myocardial infarction (MI), posterior MI, right ventricular MI, De Winter T waves, left bundle branch block with modified Sgarbossa criteria.

∗Use of the word lifestyle here refers to a collective group of modifiable risk factors. The authors wish to acknowledge that these risk factors are not solely dependent on individual choice, and instead reflect the cultural, social and environmental factors that influence behaviour. This term does not in any way attribute blame to individuals.”

ii. In the ‘Intended Audience’ section (p320), the first paragraph is changed to include paramedics.

“Intended Audience

This guideline is intended for use by all healthcare professionals involved in the care of people with ACS. These include cardiologists, emergency physicians, paramedics, general practitioners, nurses and nurse practitioners, First Nations health workers and practitioners, pharmacists and other allied healthcare professionals.”

iii. Given that prasugrel is now available in Australia, the Figure 15 footnote and abbreviations (p372) are updated.

The authors apologise for any inconvenience caused.
Original languageEnglish
Pages (from-to)e12-e13
Number of pages2
JournalHeart, Lung and Circulation
Volume35
Issue number1
DOIs
Publication statusPublished - Jan 2026

Fingerprint

Dive into the research topics of 'Corrigendum to: National Heart Foundation of Australia & Cardiac Society of Australia and New Zealand: Comprehensive Australian Clinical Guideline for Diagnosing and Managing Acute Coronary Syndromes 2025" [Heart Lung Circ. 34(4) (2025) 309-397.]'. Together they form a unique fingerprint.

Cite this